ORAL CAVITY CARCINOMA
Clinical trials for ORAL CAVITY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ORAL CAVITY CARCINOMA trials appear
Sign up with your email to follow new studies for ORAL CAVITY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Proton beam therapy may cut side effects in head and neck cancer
Disease control OngoingThis study tests whether a precise form of radiation called proton therapy works as well as standard X-ray radiation after surgery for head and neck cancer. About 174 adults with newly diagnosed head and neck cancer will receive either proton or X-ray radiation. The goal is to se…
Matched conditions: ORAL CAVITY CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
Immunotherapy duo takes on rare tumors in nationwide trial
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…
Matched conditions: ORAL CAVITY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
Diabetes drug metformin shows promise in stopping oral cancer before it starts
Prevention OngoingThis study tests whether metformin, a drug used for diabetes, can prevent oral cancer in people with precancerous mouth lesions like leukoplakia or erythroplakia. About 26 participants took metformin to see if it could shrink or eliminate these lesions. The goal is to stop cancer…
Matched conditions: ORAL CAVITY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated May 26, 2026 08:41 UTC
-
HPV vaccine under the microscope: 10-Year Follow-Up reveals hidden insights
Knowledge-focused OngoingThis study follows thousands of women in Costa Rica who received the HPV vaccine years ago, plus a new group of unvaccinated women, to see how well the vaccine works over time. Researchers are checking for cervical cell changes, immune markers, and whether the vaccine might shift…
Matched conditions: ORAL CAVITY CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 08:32 UTC